Skip to main content
Toggle navigation
Login
Search
Home
Browse by Speaker
Home
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
M
Madabushi, Rajanikanth
FDA
FDA’s Model Master Files: Paving the Path for Innovative Technologies and Increased Regulatory Acceptance of Modeling and Simulation Approaches
Location: Red Rock 8/9
Rajanikanth Madabushi
Favorite
Panel - FDA’s Model Master Files: Paving the Path for Innovative Technologies and Increased Regulatory Acceptance of Modeling and Simulation Approaches
Location: Red Rock 8/9
Rajanikanth Madabushi
Favorite
Use of Fit-for-Purpose Program to Support the Reusability of Novel Tools for New Drug Development
Location: Red Rock 8/9
Rajanikanth Madabushi
Favorite
Ma, Huilin
Bristol Myers Squibb
An immune booster: QSP modeling to advance the treatment for autoimmune diseases
Location: Willow Lake 3 - 5
Huilin Ma
Favorite
Matteson, Andrew
Certara
Certara: QSP at Scale with Certara IQ
Location: Red Rock 9
Andrew Matteson
Favorite
McGirr, Kimiko
Certara
Challenges and opportunities in integrating QSP with new modeling techniques and datatypes
Location: Colorado B-D
Kimiko McGirr
Favorite
Panel - Challenges and opportunities in integrating QSP with new modeling techniques and datatypes
Location: Colorado B-D
Kimiko McGirr
Favorite
Projecting Clinical Outcomes of Antibody-Drug Conjugates by Combining QSP and Virtual Populations
Location: Colorado B-D
Kimiko McGirr
Favorite
Meaney, Cameron
Simulations Plus
Simulations Plus: End-to-end clinical trial modeling with the Thales QSP software platform
Location: Red Rock 2
Cameron Meaney
Favorite
Mercier, Francois
Roche-Genentech
Bridging Causal Inference and Pharmacometric Modeling
Location: Willow Lake 3 - 5
Francois Mercier
Favorite
Panel - Bridging Causal Inference and Pharmacometric Modeling
Location: Willow Lake 3 - 5
Francois Mercier
Favorite
Mihaljevic, Frano
Simulations Plus
Machine learning algorithms for structural model selection - comparison and implementation
Location: Red Rock 8/9
Frano Mihaljevic
Favorite
Simulations Plus: From PK-PD Models to Simulations: A Hands-On Workshop using MonolixSuite (Day 1)
Location: Red Rock 4
Frano Mihaljevic
Favorite
Simulations Plus: From PK-PD Models to Simulations: A Hands-On Workshop using MonolixSuite (Day 2)
Location: Red Rock 4
Frano Mihaljevic
Favorite
Miyazawa, Kenji
Moderna, Inc.
Developing physiologically based PK (PBPK) models to facilitate LNP based mRNA therapeutics development
Location: Red Rock 8/9
Kenji Miyazawa
Favorite
Envisioning the Future Landscape of Quantitative Pharmacology and MIDD for Next-Generation RNA Therapeutics
Location: Red Rock 8/9
Kenji Miyazawa
Favorite
Panel - Envisioning the Future Landscape of Quantitative Pharmacology and MIDD for Next-Generation RNA Therapeutics
Location: Red Rock 8/9
Kenji Miyazawa
Favorite
Musante, Cynthia J (CJ)
Pfizer, Retired
FDA’s Model Master Files: Paving the Path for Innovative Technologies and Increased Regulatory Acceptance of Modeling and Simulation Approaches
Location: Red Rock 8/9
Cynthia J (CJ) Musante
Favorite
